Heparin modification of a biomimetic bone matrix for controlled release of VEGF
Heparin modification of a biomimetic bone matrix for controlled release of VEGF
复制标题
DOI:
10.1002/jbm.a.35020
复制
发表时间:
2014-10-01
影响因子:
4.9
通讯作者:
Gelinsky, Michael
中科院分区:
文献类型:
--
作者:
Knaack, Sven;Lode, Anja;Gelinsky, Michael
Bone regeneration using tissue engineered constructs requires strategies to effectively stimulate vascularization within such a construct that is crucial for its supply and integration with the host tissue. In this work, porous scaffolds of a collagen/hydroxyapatite nanocomposite were modified with heparin to generate biomimetic bone matrices which are able to release angiogenic factors in a controlled manner. Heparin was either integrated during material synthesis (in situ) or added to the scaffolds after their fabrication (post). Both approaches resulted in stable incorporation of heparin into the matrix of mineralized collagen. Investigations of binding and release of the vascular endothelial growth factor (VEGF-A(165)) loaded onto the scaffolds revealed an enhanced binding capacity as well as a sustained and nearly constant delivery of VEGF as result of both heparin modification methods. The release rate could be controlled by varying the quantity of incorporated heparin and the modification method. Although the biological activity of VEGF released after 7 days from the unmodified scaffolds was reduced in comparison to control VEGF, it was maintained after release from post or even enhanced after release from in situ modified scaffolds. In conclusion, the heparin-modified scaffolds of mineralized collagen exhibited favorable growth factor binding and release properties and may be beneficial to stimulate vascularization. (C) 2013 Wiley Periodicals, Inc.